The role of vaccines in COVID-19 control strategies in Singapore and China

Jintao Zhang; Hao Yang; Mengying Yang; Hao Tan

doi:10.1016/j.hlpt.2022.100620

The role of vaccines in COVID-19 control strategies in Singapore and China

Jintao Zhang
, Hao Yang
, Mengying Yang
, Hao Tan

Research output: Contribution to journal › Article › peer-review

15 Citations (Scopus)

Abstract

Objectives: In this article, we critically review the development and implementation of COVID-19 vaccination in
Singapore and China during the pandemic.
Methods: We collect and analyze data from a range of sources, including scholarly articles, statistics and documents from national governments in the two countries, and reports from international organizations.
Results: There are important differences in the two countries’ approaches to the evolving pandemic, and thus the
roles that COVID-19 vaccination plays in the overall response strategies in these two countries.
Conclusions: Whereas Singapore adopted a “living with the virus” strategy, China continued to pursue a COVIDzero strategy. The overall COVID-19 response strategy of Singapore was largely shared by many countries in the
world, while that of China was more unique and hardly imitated elsewhere. Nevertheless, vaccination played a
significant role in both countries’ responses to the pandemic. A comparison and contrast between the vaccination
processes in these two countries thus shed important light on the drivers and outcomes of COVID-19 vaccination
in different settings.

Original language	English
Article number	100620
Pages (from-to)	1-8
Number of pages	8
Journal	Health Policy And Technology
Volume	11
Issue number	2
DOIs	https://doi.org/10.1016/j.hlpt.2022.100620
Publication status	Published - Jun 2022
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/j.hlpt.2022.100620

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8957379/pdf/main.pdf

Cite this

@article{010606209bd04ef39b1da44e4a0039ae,

title = "The role of vaccines in COVID-19 control strategies in Singapore and China",

abstract = "Objectives: In this article, we critically review the development and implementation of COVID-19 vaccination in Singapore and China during the pandemic. Methods: We collect and analyze data from a range of sources, including scholarly articles, statistics and documents from national governments in the two countries, and reports from international organizations. Results: There are important differences in the two countries{\textquoteright} approaches to the evolving pandemic, and thus the roles that COVID-19 vaccination plays in the overall response strategies in these two countries. Conclusions: Whereas Singapore adopted a “living with the virus” strategy, China continued to pursue a COVIDzero strategy. The overall COVID-19 response strategy of Singapore was largely shared by many countries in the world, while that of China was more unique and hardly imitated elsewhere. Nevertheless, vaccination played a significant role in both countries{\textquoteright} responses to the pandemic. A comparison and contrast between the vaccination processes in these two countries thus shed important light on the drivers and outcomes of COVID-19 vaccination in different settings. ",

keywords = "COVID-19, Vaccination, Domestic vaccine production capacity, Vaccine rollouts, COVID-zero strategy, Living with COVID, Population density",

author = "Jintao Zhang and Hao Yang and Mengying Yang and Hao Tan",

note = "Funding Information: China's COVID-19 vaccination was also supported by its domestically produced vaccines. The Chinese government views the manufacturing of vaccines as strategically important [35] , and thus vaccine self-sufficiency has been at the center of its COVID mitigation strategy since the outbreak of the pandemic. This strategy has in turn been supported by the country's research and development and manufacturing capacity. In additon, the rapid vaccine rollout in China has been facilitated by the social memory of Chinese people. China was the first place the virus was detected in early 2020, and it undergone a very strict nationwide lockdown; thus, the Chinese were sensitive to and watchful of the potential damage COVID-19 to populous cities and regions. A survey undertaken by the Chinese Academy of Social Sciences in November 2020 indicated 60\% to 70\% of respondents had zero tolerance for the risk of COVID-19 infection and the rest were only willing to accept a 1\% risk of infection at most [36] . Publisher Copyright: {\textcopyright} 2022 Fellowship of Postgraduate Medicine",

year = "2022",

month = jun,

doi = "10.1016/j.hlpt.2022.100620",

language = "English",

volume = "11",

pages = "1--8",

journal = "Health Policy And Technology",

issn = "2211-8837",

publisher = "Fellowship of Postgraduate Medicine",

number = "2",

}

TY - JOUR

T1 - The role of vaccines in COVID-19 control strategies in Singapore and China

AU - Zhang, Jintao

AU - Yang, Hao

AU - Yang, Mengying

AU - Tan, Hao

N1 - Funding Information: China's COVID-19 vaccination was also supported by its domestically produced vaccines. The Chinese government views the manufacturing of vaccines as strategically important [35] , and thus vaccine self-sufficiency has been at the center of its COVID mitigation strategy since the outbreak of the pandemic. This strategy has in turn been supported by the country's research and development and manufacturing capacity. In additon, the rapid vaccine rollout in China has been facilitated by the social memory of Chinese people. China was the first place the virus was detected in early 2020, and it undergone a very strict nationwide lockdown; thus, the Chinese were sensitive to and watchful of the potential damage COVID-19 to populous cities and regions. A survey undertaken by the Chinese Academy of Social Sciences in November 2020 indicated 60% to 70% of respondents had zero tolerance for the risk of COVID-19 infection and the rest were only willing to accept a 1% risk of infection at most [36] . Publisher Copyright: © 2022 Fellowship of Postgraduate Medicine

PY - 2022/6

Y1 - 2022/6

N2 - Objectives: In this article, we critically review the development and implementation of COVID-19 vaccination in Singapore and China during the pandemic. Methods: We collect and analyze data from a range of sources, including scholarly articles, statistics and documents from national governments in the two countries, and reports from international organizations. Results: There are important differences in the two countries’ approaches to the evolving pandemic, and thus the roles that COVID-19 vaccination plays in the overall response strategies in these two countries. Conclusions: Whereas Singapore adopted a “living with the virus” strategy, China continued to pursue a COVIDzero strategy. The overall COVID-19 response strategy of Singapore was largely shared by many countries in the world, while that of China was more unique and hardly imitated elsewhere. Nevertheless, vaccination played a significant role in both countries’ responses to the pandemic. A comparison and contrast between the vaccination processes in these two countries thus shed important light on the drivers and outcomes of COVID-19 vaccination in different settings.

AB - Objectives: In this article, we critically review the development and implementation of COVID-19 vaccination in Singapore and China during the pandemic. Methods: We collect and analyze data from a range of sources, including scholarly articles, statistics and documents from national governments in the two countries, and reports from international organizations. Results: There are important differences in the two countries’ approaches to the evolving pandemic, and thus the roles that COVID-19 vaccination plays in the overall response strategies in these two countries. Conclusions: Whereas Singapore adopted a “living with the virus” strategy, China continued to pursue a COVIDzero strategy. The overall COVID-19 response strategy of Singapore was largely shared by many countries in the world, while that of China was more unique and hardly imitated elsewhere. Nevertheless, vaccination played a significant role in both countries’ responses to the pandemic. A comparison and contrast between the vaccination processes in these two countries thus shed important light on the drivers and outcomes of COVID-19 vaccination in different settings.

KW - COVID-19

KW - Vaccination

KW - Domestic vaccine production capacity

KW - Vaccine rollouts

KW - COVID-zero strategy

KW - Living with COVID

KW - Population density

UR - https://www.scopus.com/pages/publications/85127337162

U2 - 10.1016/j.hlpt.2022.100620

DO - 10.1016/j.hlpt.2022.100620

M3 - Article

SN - 2211-8837

VL - 11

SP - 1

EP - 8

JO - Health Policy And Technology

JF - Health Policy And Technology

IS - 2

M1 - 100620

ER -

The role of vaccines in COVID-19 control strategies in Singapore and China

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this